FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression

Eleonora Vitali, Ilena Boemi, Lorenzo Rosso, Valeria Cambiaghi, Pierluigi Novellis, Giovanna Mantovani, Anna Spada, Marco Alloisio, Giulia Veronesi, Stefano Ferrero, Andrea G. Lania

Research output: Contribution to journalArticle

Abstract

Pulmonary neuroendocrine tumors (PNTs) comprise different neoplasms, ranging from low grade carcinoids to the highly malignant small cell lung cancers. Several studies identified the cytoskeleton protein Filamin A (FLNA) as determinant in cancer progression and metastasis, but the role of FLNA in PNT aggressiveness and progression is still unknown. We evaluated FLNA expression in PNTs with different grade of differentiation, the role of FLNA in cell proliferation, colony formation, angiogenesis, cell adhesion and migration in PNT cell line (H727 cells) and primary cultures and the possible interaction between FLNA and Rap1-GTPase. FLNA is highly expressed in PNTs with high malignant grade. FLNA silencing reduces cyclin D1 levels (-51±5, p < 0.001) and cell proliferation in PNT cells (-37±4, p < 0.05), colony formation and VEGF expression (-39±9%, p < 0.01) in H727 cells. FLNA and Rap1 co-localize in cellular protrusions and FLNA silencing up-regulates Rap1 expression (+73±18%, p < 0.01). Rap1 silencing prevents cell adhesion increase (+43%±18%, p < 0.01) and cell migration decrease (-56±7%, p < 0.01) induced by FLNA silencing, without affecting cell proliferation reduction. In conclusion, FLNA is implicated in PNT progression, in part through Rap1, thus providing a potential diagnostic and therapeutic target.

Original languageEnglish
Pages (from-to)77330-77340
Number of pages11
JournalOncotarget
Volume8
Issue number44
DOIs
Publication statusPublished - 2017

Fingerprint

Filamins
Neuroendocrine Tumors
Lung
Neuroendocrine Cells
Cell Proliferation
Cell Adhesion
Cell Movement
Cell Surface Extensions
Primary Cell Culture
GTP Phosphohydrolases
Cyclin D1
Small Cell Lung Carcinoma
Carcinoid Tumor
Tumor Cell Line
Cytoskeleton
Vascular Endothelial Growth Factor A
Neoplasms

Keywords

  • Cell migration
  • Cell proliferation
  • Filamin A
  • Pulmonary neuroendocrine tumors
  • Rap1 GTPase

ASJC Scopus subject areas

  • Oncology

Cite this

FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression. / Vitali, Eleonora; Boemi, Ilena; Rosso, Lorenzo; Cambiaghi, Valeria; Novellis, Pierluigi; Mantovani, Giovanna; Spada, Anna; Alloisio, Marco; Veronesi, Giulia; Ferrero, Stefano; Lania, Andrea G.

In: Oncotarget, Vol. 8, No. 44, 2017, p. 77330-77340.

Research output: Contribution to journalArticle

Vitali, Eleonora ; Boemi, Ilena ; Rosso, Lorenzo ; Cambiaghi, Valeria ; Novellis, Pierluigi ; Mantovani, Giovanna ; Spada, Anna ; Alloisio, Marco ; Veronesi, Giulia ; Ferrero, Stefano ; Lania, Andrea G. / FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression. In: Oncotarget. 2017 ; Vol. 8, No. 44. pp. 77330-77340.
@article{215b9e7c86014156bcbdffa538361c79,
title = "FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression",
abstract = "Pulmonary neuroendocrine tumors (PNTs) comprise different neoplasms, ranging from low grade carcinoids to the highly malignant small cell lung cancers. Several studies identified the cytoskeleton protein Filamin A (FLNA) as determinant in cancer progression and metastasis, but the role of FLNA in PNT aggressiveness and progression is still unknown. We evaluated FLNA expression in PNTs with different grade of differentiation, the role of FLNA in cell proliferation, colony formation, angiogenesis, cell adhesion and migration in PNT cell line (H727 cells) and primary cultures and the possible interaction between FLNA and Rap1-GTPase. FLNA is highly expressed in PNTs with high malignant grade. FLNA silencing reduces cyclin D1 levels (-51±5, p < 0.001) and cell proliferation in PNT cells (-37±4, p < 0.05), colony formation and VEGF expression (-39±9{\%}, p < 0.01) in H727 cells. FLNA and Rap1 co-localize in cellular protrusions and FLNA silencing up-regulates Rap1 expression (+73±18{\%}, p < 0.01). Rap1 silencing prevents cell adhesion increase (+43{\%}±18{\%}, p < 0.01) and cell migration decrease (-56±7{\%}, p < 0.01) induced by FLNA silencing, without affecting cell proliferation reduction. In conclusion, FLNA is implicated in PNT progression, in part through Rap1, thus providing a potential diagnostic and therapeutic target.",
keywords = "Cell migration, Cell proliferation, Filamin A, Pulmonary neuroendocrine tumors, Rap1 GTPase",
author = "Eleonora Vitali and Ilena Boemi and Lorenzo Rosso and Valeria Cambiaghi and Pierluigi Novellis and Giovanna Mantovani and Anna Spada and Marco Alloisio and Giulia Veronesi and Stefano Ferrero and Lania, {Andrea G.}",
year = "2017",
doi = "10.18632/oncotarget.20473",
language = "English",
volume = "8",
pages = "77330--77340",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "44",

}

TY - JOUR

T1 - FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression

AU - Vitali, Eleonora

AU - Boemi, Ilena

AU - Rosso, Lorenzo

AU - Cambiaghi, Valeria

AU - Novellis, Pierluigi

AU - Mantovani, Giovanna

AU - Spada, Anna

AU - Alloisio, Marco

AU - Veronesi, Giulia

AU - Ferrero, Stefano

AU - Lania, Andrea G.

PY - 2017

Y1 - 2017

N2 - Pulmonary neuroendocrine tumors (PNTs) comprise different neoplasms, ranging from low grade carcinoids to the highly malignant small cell lung cancers. Several studies identified the cytoskeleton protein Filamin A (FLNA) as determinant in cancer progression and metastasis, but the role of FLNA in PNT aggressiveness and progression is still unknown. We evaluated FLNA expression in PNTs with different grade of differentiation, the role of FLNA in cell proliferation, colony formation, angiogenesis, cell adhesion and migration in PNT cell line (H727 cells) and primary cultures and the possible interaction between FLNA and Rap1-GTPase. FLNA is highly expressed in PNTs with high malignant grade. FLNA silencing reduces cyclin D1 levels (-51±5, p < 0.001) and cell proliferation in PNT cells (-37±4, p < 0.05), colony formation and VEGF expression (-39±9%, p < 0.01) in H727 cells. FLNA and Rap1 co-localize in cellular protrusions and FLNA silencing up-regulates Rap1 expression (+73±18%, p < 0.01). Rap1 silencing prevents cell adhesion increase (+43%±18%, p < 0.01) and cell migration decrease (-56±7%, p < 0.01) induced by FLNA silencing, without affecting cell proliferation reduction. In conclusion, FLNA is implicated in PNT progression, in part through Rap1, thus providing a potential diagnostic and therapeutic target.

AB - Pulmonary neuroendocrine tumors (PNTs) comprise different neoplasms, ranging from low grade carcinoids to the highly malignant small cell lung cancers. Several studies identified the cytoskeleton protein Filamin A (FLNA) as determinant in cancer progression and metastasis, but the role of FLNA in PNT aggressiveness and progression is still unknown. We evaluated FLNA expression in PNTs with different grade of differentiation, the role of FLNA in cell proliferation, colony formation, angiogenesis, cell adhesion and migration in PNT cell line (H727 cells) and primary cultures and the possible interaction between FLNA and Rap1-GTPase. FLNA is highly expressed in PNTs with high malignant grade. FLNA silencing reduces cyclin D1 levels (-51±5, p < 0.001) and cell proliferation in PNT cells (-37±4, p < 0.05), colony formation and VEGF expression (-39±9%, p < 0.01) in H727 cells. FLNA and Rap1 co-localize in cellular protrusions and FLNA silencing up-regulates Rap1 expression (+73±18%, p < 0.01). Rap1 silencing prevents cell adhesion increase (+43%±18%, p < 0.01) and cell migration decrease (-56±7%, p < 0.01) induced by FLNA silencing, without affecting cell proliferation reduction. In conclusion, FLNA is implicated in PNT progression, in part through Rap1, thus providing a potential diagnostic and therapeutic target.

KW - Cell migration

KW - Cell proliferation

KW - Filamin A

KW - Pulmonary neuroendocrine tumors

KW - Rap1 GTPase

UR - http://www.scopus.com/inward/record.url?scp=85030320755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030320755&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.20473

DO - 10.18632/oncotarget.20473

M3 - Article

AN - SCOPUS:85030320755

VL - 8

SP - 77330

EP - 77340

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 44

ER -